Navigation Links
ArunA Biomedical Announces Commercial Release of its Human Embryonic Stem Cell Derived Neural Cells
Date:1/30/2009

ATHENS, Ga., Jan. 30 /PRNewswire/ -- ArunA Biomedical, Inc., announced today that it will make its hN2(TM) cells commercially available to the research community in early 2009. The cells, derived from NIH registered human embryonic cell lines, are offered as a normal, consistent population of neural cells in an adherent monolayer format, a product never before offered to the research community. hN2 cells provide a human cell based format for research ranging from Alzheimer's to spinal cord injury and depression.

(Logo: http://www.newscom.com/cgi-bin/prnh/20080819/CLTU003LOGO )

"ArunA has further developed its adherent monolayer technology by creating hN2(TM), a normal human neural cell ideal for drug screening, toxicology studies and basic neural research and we are pleased to be able to offer these cells commercially to the research market," says David Ray, ArunA's Chief Executive Officer. "By offering our products through multi-national distribution partners, we will provide broad access to the unique tools that may accelerate the pace of neural research with more physiologically relevant cellular research models," Ray said.

About ArunA Biomedical

Located in Athens, Georgia, ArunA Biomedical, Inc. is a privately held biotechnology corporation dedicated to the discovery, manufacturing and commercialization of emerging new technologies in human embryonic stem cell research for use in drug discovery and basic research. ArunA is the first company to commercialize products derived from human embryonic stem cells and sees its proprietary technology as a catalyst leading to the discovery of novel therapeutic compounds, tests for neurotoxicity and breakthroughs in understanding human development and diseases. The company's first product, hNP1(TM) (ENSTem-A(TM)), is based on patented technology licensed from
'/>"/>

SOURCE ArunA Biomedical, Inc.
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. ArunA Biomedical Names William T. Sharp President and Chief Executive Officer
2. ArunA Biomedical Announces Exclusive Worldwide Technology Licensing Agreement to Commercialize Human Embryonic Stem Cell Derived Mesenchymal Cells
3. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
4. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
5. Verax Biomedical Receives 510 (k) Clearance from FDA for Platelet PGD Test
6. SLIM Search, Inc. Sponsors Next Generation Sequencing Conference for the Biomedical Market
7. NCIIA Announces Launch of 4th Annual Student Biomedical Innovation Competition
8. New Scientists Boost Disease-based Research at Boston Biomedical Research Institute
9. Foundation for Biomedical Research Board Chairman Awarded Congressional Gold Medal
10. Crux Biomedical Announces First Successful U.S. Implant of Its New Retrievable Inferior Vena Cava (IVC) Filter
11. Environmental Tectonics Corporations BioMedical Division Announces New Contract

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/2/2009)..., , SINGAPORE, Dec. 2 /PRNewswire/ ...s on its novel oral JAK2 inhibitor, SB1518, at The...g and Exposition in New Orleans. ,, Data will b... 1 dose-escalation trial of SB1518 detailing its s...namic (PK/PD) profile in dose levels ranging from ...
(Date:12/2/2009)..., , NANJING, China, Dec. 2 /PRNews...re" or the "Company") (NYSE: SCR ), a leading ph...nt, manufacturing, and marketing of branded,generi...announced that 105 of,its drugs have been included...L"), which was issued by China,s Ministry of Human...
(Date:12/2/2009)..., , SHANGHAI, Dec. 2 /PRNewswire-A...imes; markets are in turmoil and uncertainty is pa... that the pharma industry has been,relatively immu...,t take a,vacation. , During the midst of...,giant Johnson & Johnson inaugurated an R&...
(Date:12/2/2009)..., , HOBOKEN, N.J., Dec. 2 /PRNewswire/ -...0 percent to 45 percent of Americans diagnosed wit...inopathy. Diabetic retinopathy, damage to the ret...e of blindness in people with diabetes and is one ...t, up to 80 percent of all patients who,ve had dia...
Breaking Biology Technology:S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 2S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 3S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 4S*BIO Novel Oral JAK2 Inhibitor SB1518 Demonstrates Safety and Tolerability in Phase 1 Studies for the Treatment of Myeloproliferative and Other Hematological Disorders 5Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 2Simcere Announces 105 Drugs Included in China's National Drug Reimbursement List 3Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 2Pharma and Biotech Leaders to Converge in China at Asia Pharma R&D Leaders 2010 Summit 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 2Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 3Study Shows Pine Bark Improves Microcirculation, Retinal Swelling And Visual Acuity In Early Diabetic Retinopathy 4
...the leading provider of revenue cycle management f...IFIN,s CEO and Executive Chairman, Lale White, wil... New Orleans on April 28th 2009. In attendance wil...and pathologists from many of the nation,s largest...w.newscom.com/cgi-bin/prnh/20081013/LAM046LOGO ) ,...
...gin after markets close at 2:00 p.m. PT (5:00 p.m....tion (Nasdaq: MASI ), the inventor of Pulse CO-O...on pulse oximetry, today announced it will release...od ended April 4, 2009 after the market closes on ...view the results will begin at 2:00 p.m. PT (5:00 ...
...utical Institute (PI), the leading provider of spe... and biotech industry, today announced the release...s Excellence(TM) . The series was developed follo...enior training leaders from 17 large and midsize p...und that managed markets knowledge emerged as a to...
Other Biology Technology:XIFIN Inc. CEO to Speak at Executive War College Conference 2XIFIN Inc. CEO to Speak at Executive War College Conference 3Masimo to Report First Quarter 2009 Financial Results on May 5, 2009 2Masimo to Report First Quarter 2009 Financial Results on May 5, 2009 3Pharmaceutical Institute Launches New Training Series Focused on Managed Markets Excellence 2Pharmaceutical Institute Launches New Training Series Focused on Managed Markets Excellence 3
(Date:12/2/2009)...uke University Medical Center researchers have fig...cer glioma may be better able to resist radiation ...gnaling pathway in these cancer stem cells, they w...tion in a laboratory experiment. , The work bui...stem cells resist the effects of radiation much be...
(Date:12/2/2009)...e reporting the first identification of substances...at changes harmless marine bacteria into killers t...n ACS, Environmental Science & Technology , a sem...note that bleaching already has destroyed up to 30...s are searching for ways to slow or stop the damag...
(Date:12/2/2009)...ecember 2, 2009 Commonly prescribed beta 2 adrene...pregnant women as well as pre-term labor may incre...ychiatric pathology, cognitive problems and poor s...a new study published in the December 2009 issue o... . , Beta 2 adrenergic agonist drugs as a class ...
Breaking Biology News(10 mins):Discovery makes brain tumor cells more responsive to radiation 2Treatments for asthma and pre-term labor may increase risk of autism in developing fetus 2Worlds largest ocean observatory takes shape 9179 1Worlds largest ocean observatory takes shape 9179 2Worlds largest ocean observatory takes shape 9179 3The Hispanic got milk 3F Campaign Visits Chicago from July 2 July 10 51122 1The Hispanic got milk 3F Campaign Visits Chicago from July 2 July 10 51122 2Global AIDS Alliance Calls on President Obama to Honor His Campaign Promises on Global AIDS and Education 51117 1Global AIDS Alliance Calls on President Obama to Honor His Campaign Promises on Global AIDS and Education 51117 2Global AIDS Alliance Calls on President Obama to Honor His Campaign Promises on Global AIDS and Education 51117 3
...r at the University at Buffalo’s Research Institut...s own marijuana?-- called endocannabinoid -- in th...d anxiety. , A five-year, $1.7 million grant from ...ing this investigation. , “It is widely accepted... abuse marijuana is to relieve stress,?according t...
...dopamine generators (dopaminergics) in brain cells...nson,s, according to the results of tests carried ...l, led by Dr María Rosario Luquin Piudo, neurologi...sity-based medical centre, CIMA (the Research Cent...published in the latest issue of the British scien...
...have found hundreds of new marine creatures in the...ivorous sponges, free-swimming worms, crustaceans,...w insights into the evolution of ocean life. , Rep... describe how creatures in the deeper parts of the...water in the world ocean ?are likely to be related...
Other Biology News:Implanting dopamine generators in brain cells obtains improvement in Parkinson's in monkeys 2Implanting dopamine generators in brain cells obtains improvement in Parkinson's in monkeys 3Scientists discover new life in the Antarctic deep sea 2
...using Mo Bio luciferase assay. Mo Bio Laboratorie... service that will allow you to certify your produ...ble you to deliver them to your customers in a tim...10-12 /l, which will allow you to directly compete...
Mouse Anti-Glucagon-like peptide-1 (GLP-1 (1-36) amide) Monoclonal Antibody, Unconjugated, Clone 9F8 from AntibodyShop A/S
...ys: Biomedical Photometrics Inc. (Waterloo, Ontari...na, Germany) have collaborated to develop a fluore...m. The DNAscope AT is based on BPIs patented MACR...ly reads up to six ArrayTubes in sequence using a ...
...n in Early Drug Development with Imaging Mass Spec...ion data in early drug development using mass spec...etry service maps unlabeled ions and aligns them...s and metabolites prior to synthesizing radiolabel...
Biology Products: